ArticleResearch (Washington, D.C.)2025

Gene Signature-Based Drug Screening Reveals Ponatinib Enhances Immunotherapy Efficacy in Triple-Negative Breast Cancer by Reversing MDSC-Mediated Immunosuppressive Tumor Microenvironment.

Qianyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.